Synthetic collagen from maize has human properties

June 24, 2011

Synthetic collagen has a wide range of applications in reconstructive and cosmetic surgery and in the food industry. For proper function in animals a certain number of prolines within the protein need to be hydroxylated. BioMed Central's open access journal BMC Biotechnology reports that for the first time the α1 chain of type 1 collagen has been produced in maize with similar levels of proline hydroxylation to human collagen.

Most used is derived from animals but there are risks associated with this collagen containing infectious agents or being rejected by the body. To avoid this problem several laboratory–based systems have been developed using plants to produce collagen. Plant-derived recombinant proteins should have lower contamination and fewer infectious agents, but these systems are unable to make modifications to the protein essential for proper function in human cells.

Working in collaboration with industrial partners researchers added a gene, which codes for the α1 chain of human CI (hCI α1), to maize along with genes which make human prolyl 4-hydroxylase. This second protein was able to hydroxylate approximately the same percentage of prolines in the recombinant collagen α1 chain, produced in maize, as seen for human collagen made in human cells.

Dr Kan Wang from Iowa State University said, "Producing human collagen in maize seeds is an inexpensive alternative to using animal-derived collagen. The seeds are easy to grow, process, and store. Our transgenic plant system is also able to produce a protein with human-like modifications making it a better choice for a wide range of applications."

Explore further: Collagen manufactured from transgenic tobacco plants

More information: Hydroxylation of recombinant human collagen type I alpha 1 in transgenic maize co-expressed with a recombinant human prolyl 4-hydroxylase, Xing Xu, Qinglei Gan, Richard C Clough, Kamesh M Pappu, John A Howard, Julio A Baez and Kan Wang, BMC Biotechnology (in press)

Related Stories

Collagen manufactured from transgenic tobacco plants

June 10, 2010

A scientist at the Hebrew University of Jerusalem's Robert H. Smith Faculty of Agriculture, Food and Environment has succeeded in producing a replica of human collagen from tobacco plants - an achievement with tremendous ...

Scientists create super-strong collagen

January 12, 2010

(PhysOrg.com) -- A team of University of Wisconsin-Madison researchers has created the strongest form of collagen known to science, a stable alternative to human collagen that could one day be used to treat arthritis and ...

Research reveals structure and behavior of collagen

February 26, 2008

The structure and behavior of one of the most common proteins in our bodies has been resolved at a level of detail never before seen, thanks to new research performed at the Advanced Photon Source (APS) at the U.S. Department ...

Gene Gives a Boost to Tumor Suppression

August 18, 2006

Angiogenesis, or the growth of new blood vessels, is an important naturally occurring process in the body. As with normal tissues, tumors rely on angiogenesis to supply them with the oxygen and nutrients they need for growth.

Another new wrinkle in treating skin aging

June 5, 2008

Topical applications of a naturally occurring fat molecule have the potential to slow down skin aging, whether through natural causes or damage, researchers report.

Recommended for you

Blueprint for shape in ancient land plants

December 9, 2016

Scientists from the Universities of Bristol and Cambridge have unlocked the secrets of shape in the most ancient of land plants using time-lapse imaging, growth analysis and computer modelling.

Protein disrupts infectious biofilms

December 8, 2016

Many infectious pathogens are difficult to treat because they develop into biofilms, layers of metabolically active but slowly growing bacteria embedded in a protective layer of slime, which are inherently more resistant ...

An anti-CRISPR for gene editing

December 8, 2016

Researchers have discovered a way to program cells to inhibit CRISPR-Cas9 activity. "Anti-CRISPR" proteins had previously been isolated from viruses that infect bacteria, but now University of Toronto and University of Massachusetts ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.